CClinicalTrials.gg
CompletedNCT02590237Updated Oct 3, 2016

KingVision Video Laryngoscopy vs Direct Laryngoscopy - Equivalence Trial

An interventional study of Ambu KingVision Video Laryngoscope aBlade and Miller Direct Laryngoscopy in Tracheal Intubation, sponsored by Ann & Robert H Lurie Children's Hospital of Chicago. Completed at 1 site in United States. Open to participants aged Up to 2 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2016-10-03.

Sponsored by Ann & Robert H Lurie Children's Hospital of Chicago · Not applicable and Interventional

Phase
Not applicable
Study type
Interventional
Enrollment
200
Allocation
Randomized
Ages
Up to 2 Years
Sex
All
01

Study summary

The purpose of this study is to determine whether the Ambu KingVision videolaryngoscope performs as well as direct laryngoscopy for intubating small children and infants.

Read the detailed description

The goal of this prospective randomized study is to compare the Ambu KingVision Video Laryngoscope and direct laryngoscopy using the Miller Blade Laryngoscope.

The primary outcome of the study will be time to successful intubation. Other outcomes of clinical relevance such as first attempt success rates of intubation, grade of laryngeal view, percentage of glottic opening, number of insertion attempts, hemodynamic responses, and complications will also be assessed.

02

Conditions studied

  • Tracheal Intubation

Keywords

  • Laryngoscopy
  • Video Laryngoscopy
03

In context

Lead sponsor

Ann & Robert H Lurie Children's Hospital of Chicago is the lead sponsor of 176 studies on the registry; 30 are open to participants now.

Of its 10 completed or terminated interventional studies of FDA-regulated products, 5 (50%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Up to 2 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Patients at Lurie Children's Hospital undergoing surgery/procedure where intubation is indicated
  • American Society of Anesthesiology Class I-III patients

Exclusion criteria

Exclusion Criteria:

  • Children with an expected difficult airway
  • A bleeding or blood clotting disorder
05

Study design

Phase
Not applicable
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
200 participants (actual)

Study arms

  • Active comparator
    Direct Laryngoscopy

    The trachea will be intubated via direct laryngoscopy using a traditional straight blade (Miller) laryngoscope.

    Device: Miller Direct Laryngoscopy

  • Experimental
    KingVision Video Laryngoscope

    The trachea will be intubated using the Ambu KingVision Video Laryngoscope size 1 pediatric blade.

    Device: Ambu KingVision Video Laryngoscope aBlade

Interventions

  • DeviceAmbu KingVision Video Laryngoscope aBlade

    At time of tracheal intubation, the subject will be intubated using the Ambu KingVision Video Laryngoscope with a size 1 aBlade. The first attempt to successful intubation will be assessed. The Cormack Lehane and Percentage of Glottic Opening scores will be recorded. Information on time to glottic view, time to removal of the blade, and time of first capnography upstroke (successful intubation) will be recorded. Other parameters measured will be information on subsequent attempts, ease of tracheal tube insertion, and hemodynamic responses for 5 minutes.

  • DeviceMiller Direct Laryngoscopy

    At time of tracheal intubation, the subject will be intubated using a Miller blade laryngoscope. The first attempt to successful intubation will be assessed. The Cormack Lehane and Percentage of Glottic Opening scores will be recorded. Information on time to glottic view, time to removal of the blade, and time of first capnography upstroke (successful intubation) will be recorded. Other parameters measured will be information on subsequent attempts, ease of tracheal tube insertion, and hemodynamic responses for 5 minutes.

06

What researchers measure

Primary outcomes

  1. Time to Intubation

    Three timepoints will be recorded, beginning with insertion of the device past the lips into the mouth. These will include time to optimal glottic view, time to removal of device from mouth, and time to first CO2 capnography upstroke. The primary outcome measure will be total time to intubation, as the sum of all three timepoints.

    Time frame: Assessed intraoperatively at time of intubation

Secondary outcomes

  1. First Attempt Success Rate of Tracheal Intubation

    An attempt at tracheal intubation will be defined as entry of the device into the patient's mouth without the need to remove the device once entered and securing the airway.

    Time frame: Assessed intraoperatively at time of intubation

  2. Grades of Laryngeal View

    Cormack Lehane (1-4) and percentage of glottic opening (POGO) (%) will be recorded after insertion of the laryngoscope

    Time frame: Assessed intraoperatively at time of intubation

  3. Intubation Adjustments & Ease of Use

    Airway manipulations utilized and ease of use (Likert 1-5) will be assessed by the user following the intubation.

    Time frame: Assessed intraoperatively following intubation

  4. Hemodynamic Parameters - Heart Rate

    Heart rate (beats per minute) will be assessed prior to intubation and at 1 minute intervals, for 5 minutes, following intubation.

    Time frame: Assessed intraoperatively at time of and following intubation

  5. Hemodynamic Parameters - Blood Pressure

    Blood pressure (mmHg) will be assessed prior to intubation and at 1 minute intervals, for 5 minutes, following intubation.

    Time frame: Assessed intraoperatively at time of and following intubation

  6. Intraoperative Complications

    Airway/device related complications including, laryngospasm, bronchospasm, oxygen desaturation, will be assessed at intubation, during the surgery, and after extubation while under the anesthesiologists care.

    Time frame: Assessed intraoperatively

  7. Postoperative Complications

    Airway/device related complications including sore throat, hoarseness, persistent coughing, stridor, and others will be assessed in the post anesthesia care unit.

    Time frame: Assessed postoperatively while admitted to the phase 1 recovery unit, approximately 30-60 minutes after surgery

07

Study locations

1 site
  • Ann & Robert H Lurie Children's Hospital of Chicago
    Chicago, Illinois 60611, United States
08

References and documents

Publications

  • Levitan RM, Heitz JW, Sweeney M, Cooper RM. The complexities of tracheal intubation with direct laryngoscopy and alternative intubation devices. Ann Emerg Med. 2011 Mar;57(3):240-7. doi: 10.1016/j.annemergmed.2010.05.035. Epub 2010 Jul 31. PubMed 20674088 ↗
  • Theiler L, Hermann K, Schoettker P, Savoldelli G, Urwyler N, Kleine-Brueggeney M, Arheart KL, Greif R. SWIVIT--Swiss video-intubation trial evaluating video-laryngoscopes in a simulated difficult airway scenario: study protocol for a multicenter prospective randomized controlled trial in Switzerland. Trials. 2013 Apr 4;14:94. doi: 10.1186/1745-6215-14-94. PubMed 23556410 ↗
  • Murphy LD, Kovacs GJ, Reardon PM, Law JA. Comparison of the king vision video laryngoscope with the macintosh laryngoscope. J Emerg Med. 2014 Aug;47(2):239-46. doi: 10.1016/j.jemermed.2014.02.008. Epub 2014 Apr 16. PubMed 24742495 ↗
  • Akihisa Y, Maruyama K, Koyama Y, Yamada R, Ogura A, Andoh T. Comparison of intubation performance between the King Vision and Macintosh laryngoscopes in novice personnel: a randomized, crossover manikin study. J Anesth. 2014 Feb;28(1):51-7. doi: 10.1007/s00540-013-1666-9. Epub 2013 Jun 30. PubMed 23812581 ↗
  • Jagannathan N, Hajduk J, Sohn L, Huang A, Sawardekar A, Albers B, Bienia S, De Oliveira GS. Randomized equivalence trial of the King Vision aBlade videolaryngoscope with the Miller direct laryngoscope for routine tracheal intubation in children <2 yr of age. Br J Anaesth. 2017 Jun 1;118(6):932-937. doi: 10.1093/bja/aex073. PubMed 28549081 ↗
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Oct 3, 2016, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02590237
Lead sponsor
Ann & Robert H Lurie Children's Hospital of Chicago
Responsible party
Narasimhan Jagannathan (Primary Investigator, Ann & Robert H Lurie Children's Hospital of Chicago) — Principal investigator
First posted
Oct 28, 2015
Start date
Oct 2015
Primary completion
Sep 2016
Completion
Sep 2016
Last update
Oct 3, 2016

Study contacts

Narasimhan Jagannathan, MD
principal investigator · Ann & Robert Lurie Children's Hospital of Chicago

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2016. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion